Neurocrine Biosciences NBIX reported its Q3 earnings results on Monday, November 1, 2021 at 04:01 PM.
Here's what investors need to know about the announcement.
Neurocrine Biosciences reported in-line EPS of $0.64 versus an estimate of $0.6, which did not surprise analysts.
Revenue was up $37,500,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.14, which was followed by a 4.61% drop in the share price the next day.
Here's a look at Neurocrine Biosciences's past performance:
|Quarter||Q2 2021||Q1 2021||Q4 2020||Q3 2020|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.